With the increasing use of intravitreal administration of corticosteroids in macular edema, steroid-induced intraocular pressure (IOP) rise is becoming an emergent issue. However, for patients in whom intravitreal steroids are indicated, there are no specific recommendations for IOP monitoring and management after intravitreal administration of corticosteroids.status: publishe
International audienceINTRODUCTION: The 0.19 mg fluocinolone acetonide (FAc) intravitreal implant de...
International audienceINTRODUCTION: The 0.19 mg fluocinolone acetonide (FAc) intravitreal implant de...
International audienceINTRODUCTION: The 0.19 mg fluocinolone acetonide (FAc) intravitreal implant de...
Introduction: With the increasing use of intravitreal administration of corticosteroids in macular e...
With the increasing use of intravitreal administration of corticosteroids in macular edema, steroid-...
INTRODUCTION: With the increasing use of intravitreal administration of corticosteroids in macular e...
Intravitreal therapy for diabetic macular edema can, in susceptible patients, increase intraocular p...
Intravitreal therapy for diabetic macular edema can, in susceptible patients, increase intraocular p...
Intravitreal therapy for diabetic macular edema can, in susceptible patients, increase intraocular p...
<p><b>Article full text</b></p> <p><br></p> <p>The full text of this article can be found here<b>....
Aims: Intravitreal steroid implants have emerged as an adjunctive therapy in diabetic macular edema ...
Aim: To investigate the intraocular pressure (IOP) response after intravitreal injections of triamci...
BACKGROUND AND OBJECTIVE: To compare elevated intraocular pressure (IOP) management and outcomes amo...
Objectives: To investigate the effect of intravitreal triamcinolone acetonide (IVTA) used for the ma...
International audienceINTRODUCTION: The 0.19 mg fluocinolone acetonide (FAc) intravitreal implant de...
International audienceINTRODUCTION: The 0.19 mg fluocinolone acetonide (FAc) intravitreal implant de...
International audienceINTRODUCTION: The 0.19 mg fluocinolone acetonide (FAc) intravitreal implant de...
International audienceINTRODUCTION: The 0.19 mg fluocinolone acetonide (FAc) intravitreal implant de...
Introduction: With the increasing use of intravitreal administration of corticosteroids in macular e...
With the increasing use of intravitreal administration of corticosteroids in macular edema, steroid-...
INTRODUCTION: With the increasing use of intravitreal administration of corticosteroids in macular e...
Intravitreal therapy for diabetic macular edema can, in susceptible patients, increase intraocular p...
Intravitreal therapy for diabetic macular edema can, in susceptible patients, increase intraocular p...
Intravitreal therapy for diabetic macular edema can, in susceptible patients, increase intraocular p...
<p><b>Article full text</b></p> <p><br></p> <p>The full text of this article can be found here<b>....
Aims: Intravitreal steroid implants have emerged as an adjunctive therapy in diabetic macular edema ...
Aim: To investigate the intraocular pressure (IOP) response after intravitreal injections of triamci...
BACKGROUND AND OBJECTIVE: To compare elevated intraocular pressure (IOP) management and outcomes amo...
Objectives: To investigate the effect of intravitreal triamcinolone acetonide (IVTA) used for the ma...
International audienceINTRODUCTION: The 0.19 mg fluocinolone acetonide (FAc) intravitreal implant de...
International audienceINTRODUCTION: The 0.19 mg fluocinolone acetonide (FAc) intravitreal implant de...
International audienceINTRODUCTION: The 0.19 mg fluocinolone acetonide (FAc) intravitreal implant de...
International audienceINTRODUCTION: The 0.19 mg fluocinolone acetonide (FAc) intravitreal implant de...